Z-2333-2021 Class II Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-2333-2021 was initiated by Becton, Dickinson And Company, BD Biosciences on Jul 22, 2021 and is designated Class II. Reason for recall: Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive… The recall status is terminated (terminated Mar 24, 2023). Affected quantity: 23 reagents.

Recall details

Product Type
Devices
Report Date
Sep 1, 2021
Initiation Date
Jul 22, 2021
Termination Date
Mar 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23 reagents

Product description

BD" Mouse IgG2a Isotype Control APC X39 ASR

Reason for recall

Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive staining due to contamination with another antibody.

Distribution pattern

Worldwide distribution - U.S. Nationwide distribution in the states of CT, FL, KY, NY, and PA. The country of Taiwan.

Code information

Catalog Number: 340757 UDI: 00382903407576 Lot Number: 0253432

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2333-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2333-2021. Report a data issue: hello@regdatalab.com.